Gossamer Bio Funding & Investors
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
gossamerbio.comTotal Amount Raised: $812,000,000
Gossamer Bio Funding Rounds
Post Ipo Equity
$212,000,000
Post Ipo Equity Investors
Farallon Capital ManagementEcoR1 CapitalSamsara BioCapitalNew Enterprise Associates (NEA)SilverArc CapitalBoxer CapitalPalo Alto InvestorsInvusOctagon Capital AdvisorsArmistice CapitalMadison Avenue PartnersRock Springs CapitalNantahala Capital ManagementFederated Kaufmann FundPost Ipo Equity
$120,000,000
Post Ipo Equity Investors
Rock Springs CapitalMadison Avenue PartnersNew Enterprise Associates (NEA)Weiss Asset ManagementInvusMonashee Investment ManagementBoxer CapitalEcoR1 CapitalPost Ipo Debt
$150,000,000
Post Ipo Debt Investors
MidCap FinancialSeries B
$230,000,000
Series B Investors
Hillhouse InvestmentPolaris PartnersBaupost GroupOmega FundsInvusAbu Dhabi Investment AuthorityArch Venture PartnersBay City CapitalSeries A
$100,000,000
Series A Investors
Arch Venture PartnersOmega Funds
Funding info provided by Diffbot.